This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Clinical Data Disclosure Europe
7-8 November, 2024
Amsterdam Marriott HotelAmsterdam, The Netherlands
7-8 November, 2024
Amsterdam Marriott Hotel,
Amsterdam, The Netherlands


Network With Your Leading Clinical Data Disclosure, Transparency & Plain Language Summaries Community - Benchmark, Be Inspired And Prepare To Meet Regulatory Mandates With Fellow Industry Professionals

Is the disclosure of data truly beneficial for patients?

  • Is data being properly disclosed?
  • Is disclosed data accessible?
  • How is this data being utilised and is it bringing value
  • Is the disclosure of data making good on its prospects
  • Is the process through the CTIS patient centric, take the example of plain language summaries

Nov 07, 3:35pm

Evaluation of guidance, developing of best practices and leveraging innovative solutions to protect personal data and commercially confidential information (CCI)

  • Join in on an insightful discussion between industry experts who pick apart the interim guidance document provided by the European Medicines Agency on protecting personal data and commercially confidential information while using CTIS
  • Hear from various experts and thought leaders in the field on how they are applying guidelines and taking further innovative steps to create their own best practices to remain fully compliant
  • Get updated on what the industry leaders think are the best solutions out there to utilise including AI and machine learning
  • Understand the importance of protecting personal data and commercially confidential information. Build your confidence in document curation and submission while ensuring your company’s information is kept concealed
  • Level up your data disclosure know-how to help elevate clinical research while retaining compliance excellence

Nov 06, 4:05pm